Aprea Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Aprea Therapeutics

10/08/2023 14:57

* Aprea Therapeutics Inc  APRE.OQ  reported a quarterly
adjusted
loss of 87 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of $1.42 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Aprea Therapeutics Inc's reported EPS for the quarter was
a loss
of 87 cents​.
    * The mean earnings estimate of analysts had risen by
about 17.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Aprea Therapeutics Inc shares had risen by 23.2% this
quarter and lost 41.4% so far this year.
    * The company reported a quarterly loss of $3.26 million.
    * Wall Street's median 12-month price target for Aprea
Therapeutics Inc is $16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 01:57 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.42          -0.87          Beat
 Mar. 31 2023      -1.50          -1.34          Beat
 Dec. 31 2022      -3.08          -0.92          Beat
 Sep. 30 2022      -5.50          -2.40          Beat